Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP versus methylprednisolone for frozen shoulder
IRCT20240506061680N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Oct 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of platelet-rich plasma, methylprednisolone and lidocaine in adhesive capsulitis (AC) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Visual Analog Scale at 24 weeks, Range of motion at 24 weeks and 2 more. Started Oct 2024; status: completed.
02
Drugs
platelet-rich plasmamethylprednisolonelidocaine
03
Conditions
adhesive capsulitis (AC)
Beyond the preview
Go deeper on IRCT20240506061680N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240506061680N1.